Announced Tue, 14 Jul · 19:02 IST
Board meeting on July 21 to approve Q1FY27 financial results
Results View source PDF
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.2%1-day move
₹749.95
prior close
₹754.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.5-0.5-0.5+1.2+3.7+5.2+5.9+3.9+2.6————
Up moveDown movePending
AI summary
Anthem Biosciences has scheduled a Board meeting on July 21, 2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The trading window for dealing in equity shares is closed from July 01 to July 23, 2026, in line with SEBI insider trading rules. Results will be published after board approval.
Likely market impact
Routine quarterly results intimation. Watch for actual numbers and management commentary when results are declared on or after July 21, 2026.